Skip to content

← All news

Markets

TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study - Slideshow

1 source ·1 article ·Sep 4, 23:07 UTC TScan Therapeutics Information Services

Covered by 1 outlet

All coverage · 1 article

Seeking Alpha ·Sep 4, 23:07 UTC

TScan Therapeutics, Inc. (TCRX) Discusses Strategic Refocus on In Vivo Cell Therapy for Solid Tumors and Pausing of Phase III Heme Study - Slideshow